Somatuline Depot

Somatuline^® Depot (lanreotide) Injection needed to enter a market against a deeply entrenched competitor with a 20-year track record in treating acromegaly, the excess production of the growth hormones IGF-1 and GH. To quickly differentiate the product, we built on the idea of "freedom" to convey its efficacy and significant convenience advantages (such as its prefilled syringe and lower injection volume). The campaign features cleverly themed license plates—EZ 4 U, EFFECTV, TOLRABL—to detail the product’s benefits.